Alyeska Investment Group
MAIA icon

Alyeska Investment Group’s MAIA Biotechnology MAIA Stock Holding History

Alyeska Investment Group’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Hold
2,500,000
– – 0.01% 534
2026
Q1 		$3.5M Buy
+2,500,000
New +$4.61M 0.01% 511

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Alyeska Investment Group's MAIA Position: Q2 2026 in Review

Alyeska Investment Group held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 2,500,000 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #534.

Alyeska Investment Group first reported a position in MAIA in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Alyeska Investment Group held 2,500,000 shares of MAIA Biotechnology worth $3.6M as of Q2 2026.
  • Alyeska Investment Group left its MAIA Biotechnology share count unchanged in Q2 2026.
  • MAIA Biotechnology made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #534 holding.
  • Alyeska Investment Group first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.